CHRS short interest
Coherus Oncology Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 23,337,539 |
|---|---|
| Change vs prior report | 488,554 (+2.1%) |
| Change over six months | -17.1% |
| Days to cover | 12.53 (sector: 3.78) |
| Average daily volume | 1,863,260 |
| Rank in Healthcare | #66 of 922 by days to cover |
CHRS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 23,337,539 | +2.1% | 12.53 | 1,863,260 |
| 2026-09-15 | 22,848,985 | -4.5% | 32.76 | 697,553 |
| 2026-08-31 | 23,915,667 | -0.3% | 16.84 | 1,420,425 |
| 2026-08-14 | 23,997,214 | -2.2% | 19.71 | 1,217,659 |
| 2026-07-31 | 24,527,052 | +2.7% | 53.59 | 457,684 |
| 2026-07-15 | 23,885,705 | -8.0% | 24.36 | 980,714 |
| 2026-06-30 | 25,975,163 | +1.3% | 21.88 | 1,186,988 |
| 2026-06-15 | 25,637,521 | -8.0% | 33.41 | 767,402 |
| 2026-05-29 | 27,872,603 | -0.8% | 23.66 | 1,177,971 |
| 2026-05-15 | 28,108,039 | +1.0% | 17.16 | 1,637,849 |
| 2026-04-30 | 27,818,409 | -0.6% | 25.51 | 1,090,609 |
| 2026-04-15 | 27,972,356 | -0.6% | 34.70 | 806,094 |
| 2026-03-31 | 28,142,006 | +0.4% | 20.68 | 1,361,137 |
| 2026-03-13 | 28,025,097 | +1.3% | 17.49 | 1,602,561 |
| 2026-02-27 | 27,657,585 | -6.6% | 20.59 | 1,343,318 |
| 2026-02-13 | 29,614,243 | +0.1% | 12.22 | 2,423,063 |
| 2026-01-30 | 29,597,546 | -0.5% | 5.77 | 5,129,635 |
| 2026-01-15 | 29,738,849 | +2.3% | 18.03 | 1,649,187 |
| 2025-12-31 | 29,066,312 | -2.6% | 38.11 | 762,713 |
| 2025-12-15 | 29,855,093 | +0.7% | 29.33 | 1,017,748 |
| 2025-11-28 | 29,639,306 | +1.6% | 28.21 | 1,050,841 |
| 2025-11-14 | 29,176,605 | -3.1% | 16.77 | 1,739,319 |
| 2025-10-31 | 30,098,437 | -0.2% | 33.32 | 903,300 |
| 2025-10-15 | 30,165,888 | -3.1% | 28.00 | 1,077,354 |
| 2025-09-30 | 31,138,131 | -2.3% | 19.93 | 1,562,287 |
import finzdata as yf
yf.Ticker("CHRS").short_interest # every report since 2017
yf.Client().short_interest(["CHRS"], start="2018-01-01")Healthcare short interest · CHRS price history · Who owns CHRS · All short interest